Before Your Biopsy: How to Talk to Your Doctor About Cryopreserving Your Tissue — Because Preserving Tissue Means Preserving Treatment Options

What Most Patients Don’t Realize Until It’s Too Late

If you or someone you love is preparing for a biopsy, surgery, or tumor removal, one critical question could dramatically impact your future treatment options:

“Can my tissue be cryopreserved for advanced testing and future treatment planning?”

Most patients are never told to ask.

And that’s a problem.

Today, standard biopsy preservation often relies on FFPE (formalin-fixed paraffin-embedded tissue), a method that has been around for nearly 100 years. While FFPE works for basic diagnostics, it can significantly limit many forms of modern advanced testing, treatment effectiveness screening, personalized medicine applications, and certain clinical trial opportunities.

The reality:

• Nearly 50% of first-line cancer treatments fail
• Many patients later wish they had preserved more viable tissue
• Once tissue is processed traditionally, many future opportunities may be lost forever
• A second biopsy may be invasive, risky, costly, or impossible

Fear of Missing Out Is Real — Because This Decision May Only Happen Once

For many patients, the biopsy is their one and only opportunity to properly preserve living tumor tissue for:

• Immediate treatment effectiveness testing
• Drug sensitivity analysis
• Genomic profiling
• Personalized vaccine development
• Immunotherapy guidance
• Future advanced diagnostics
• Expanded clinical trial eligibility
• Long-term medical innovation as new therapies emerge

In simple terms:

If you don’t preserve it now, you may lose access to future options later.

Questions to Ask Your Doctor Before Your Procedure

Bring these questions to your physician, oncologist, surgeon, or care team:

Important Questions:

• “Can additional tissue be collected beyond standard pathology requirements?”
• “Can my tissue be cryopreserved instead of only FFPE preserved?”
• “Can my tissue be stored for future advanced treatment testing?”
• “What options do I have if my first treatment fails?”
• “How can I preserve access to future therapies and clinical trials?”

Why This Conversation Matters

Many physicians are focused on diagnosis and immediate care, but cancer treatment is evolving rapidly.

New technologies are emerging constantly.

Cryopreservation gives patients the ability to potentially benefit from:

• New therapies
• AI-driven diagnostics
• Future biomarkers
• Expanded precision medicine
• Research breakthroughs years down the road

Without preserved tissue:

Your future options may narrow significantly.

Cost vs. Value: A Small Investment for Potentially Life-Changing Access

Out-of-pocket costs for long-term tissue cryopreservation are often:

Less than $1,000 upfront

With affordable long-term storage options

Additionally:

Some insurance providers are beginning to offer partial or full coverage.

Compared to:

• Repeat biopsies
• Delayed treatment optimization
• Lost clinical trial access
• Missed therapeutic opportunities

Cryopreservation can represent one of the most important proactive healthcare investments a patient can make.

Bottom Line: Preserve Your Tissue. Preserve Your Choices.

Cancer care is increasingly personalized.

Your tissue may hold the key to:

• Better treatment matching
• More effective therapies
• Faster pivots if treatment fails
• Access to future innovation

Don’t let lack of information cost you options.

Advocate for yourself.

Ask questions.

Preserve your tissue.

Preserve your future.

Preserving Tissue Means Preserving Hope.

For more information on cryopreservation, treatment effectiveness testing, and long-term biospecimen storage, contact SpeciCare today.